연구성과로 돌아가기

2022 연구자 정보 (27 / 1074)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Jung, Hyun Ae
(Jung, HA)
Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol, Seoul, South Korea
Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Hematol Oncol,Sch Med, Seoul, South Korea


[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies
[JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies
SCIE 1.9 ONCOLOGY
BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY
sanjay.popat@rmh.nhs.uk;
Kim, Gwanghyun
(Kim, G)
Korea Adv Inst Sci & Technol KAIST, Daejeon, South Korea
Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea


[JCR상위 1.9] Multi-task vision transformer using low-level chest X-ray feature corpus for COVID-19 diagnosis and severity quantification
[JCR상위 7.5] Self-evolving vision transformer for chest X-ray diagnosis through knowledge distillation
SCIE 1.9 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
MULTIDISCIPLINARY SCIENCES
jong.ye@kaist.ac.kr;
Kim, Jin Hwan
(Kim, JH)
Chungnam Natl Univ, Coll Med, Daejeon, South Korea
Chungnam Natl Univ, Coll Med, Chungnam Natl Univ Hosp, Dept Radiol, Daejeon 35015, South Korea
KFS-3069-2024
Kim, Juhee

[JCR상위 1.9] Multi-task vision transformer using low-level chest X-ray feature corpus for COVID-19 diagnosis and severity quantification
[JCR상위 7.5] Self-evolving vision transformer for chest X-ray diagnosis through knowledge distillation
[JCR상위 29.4] Development and Validation of a Multimodal-Based Prognosis and Intervention Prediction Model for COVID-19 Patients in a Multicenter Cohort
SCIE 1.9 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
MULTIDISCIPLINARY SCIENCES
CHEMISTRY, ANALYTICAL;ENGINEERING, ELECTRICAL & ELECTRONIC;INSTRUMENTS & INSTRUMENTATION
jong.ye@kaist.ac.kr;
sosal@snu.ac.kr;johnahn92@lunit.io;mj1.chung@samsung.com;jeongyj@pusan.ac.kr;michelan@cnu.ac.kr;limjaekwang@gmail.com;jinkim0411@naver.com;youngjae@gachon.ac.kr;rollycandy2@naver.com;oneshot0229@gmail.com;
Kim, T.
(Kim, T)
Univ Ulsan, Med Ctr, Coll Med, Seoul, South Korea
Kyungpook Natl Univ, Dept Astron & Atmospher Sci, Daegu 41566, South Korea


[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer
[JCR상위 12.3] Stellar masses, sizes, and radial profiles for 465 nearby early-type galaxies: An extension to the Spitzer survey of stellar structure in Galaxies (S⁴G)
SCIE 1.9 ONCOLOGY
ASTRONOMY & ASTROPHYSICS
a.emery.watkins@gmail.com;
Kwiatkowski, M.
(Kwiatkowski, M)
Szpital Wojewodzki Mikolaja Kopernika Koszalini, Koszalin, Poland

[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer SCIE 1.9 ONCOLOGY
Leconte, P.
(Leconte, P)
MSD France, Paris, Puteaux, France

[JCR상위 1.9] Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer SCIE 1.9 ONCOLOGY
Lee, Seung Hyeun
(Lee, SH)
Kyung Hee Univ, Sch Med, Med Ctr, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea
Kyung Hee Univ, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med,Med Ctr, Seoul, South Korea
P-5566-2018
Lee, Seung Hyeun
0000-0002-7666-313X
Lee, Seung Hyeun
[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies
[JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies
SCIE 1.9 ONCOLOGY
BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY
sanjay.popat@rmh.nhs.uk;
Lee, Yong Chul
(Lee, YC)
Chonbuk Natl Univ, Biomed Res Inst, Chonbuk Natl Univ Hosp, Dept Internal Med,Res Inst Clin Med, Jeonju, South Korea
Jeonbuk Natl Univ, Res Ctr Pulm Disorders, Dept Internal Med, Med Sch, Jeonju, South Korea


[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies
[JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies
SCIE 1.9 ONCOLOGY
BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY
sanjay.popat@rmh.nhs.uk;
Maerten, Angela
(Märten, A)
Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies SCIE 1.9 ONCOLOGY
Makowsky, M.
(Makowsky, M)
AstraZeneca, Gaithersburg, MD USA

[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study SCIE 1.9 ONCOLOGY
Marcovitz, M.
(Marcovitz, M)
AstraZeneca, Gaithersburg, MD USA

[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study SCIE 1.9 ONCOLOGY
Masi, G.
(Masi, G)
Univ Pisa, Azienda Osped Univ Pisana, Unit Med Oncol, Dept Translat Res & New Technol Med & Surg, Pisa, Italy

[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study SCIE 1.9 ONCOLOGY
Miura, Satoru
(Miura, S)
제1저자 Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan

[JCR상위 1.9] Sequential afatinib and osimertinib in Asians with EGFRm plus NSCLC: combined analysis of two non-interventional studies
[JCR상위 34.5] Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional Studies
SCIE 1.9 ONCOLOGY
BIOTECHNOLOGY & APPLIED MICROBIOLOGY;ONCOLOGY
sanjay.popat@rmh.nhs.uk;
Moon, Sungjun
(Moon, S)
Yeungnam Univ, Coll Med, Daegu, South Korea
0000-0002-3920-7004
Moon, Sungjun
[JCR상위 1.9] Multi-task vision transformer using low-level chest X-ray feature corpus for COVID-19 diagnosis and severity quantification
[JCR상위 7.5] Self-evolving vision transformer for chest X-ray diagnosis through knowledge distillation
SCIE 1.9 COMPUTER SCIENCE, ARTIFICIAL INTELLIGENCE;COMPUTER SCIENCE, INTERDISCIPLINARY APPLICATIONS;ENGINEERING, BIOMEDICAL;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
MULTIDISCIPLINARY SCIENCES
jong.ye@kaist.ac.kr;
Negro, A.
(Negro, A)
AstraZeneca, Gaithersburg, MD USA

[JCR상위 1.9] Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study SCIE 1.9 ONCOLOGY
페이지 이동: